Evidence map›Paper›PMID 26044585›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2015

Chromatin Modifications Associated With Diabetes and Obesity.

Dustin E Schones, Amy Leung, Rama Natarajan

Open access · bronzeAbstract readReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Plasma microRNA Profiling in Type 2 Diabetes Mellitus: A Pilot Study.International journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Diabetes Induces a Transcriptional Signature in Bone Marrow-Derived CD34International journal of molecular sciences · 2021
    Article
  8. Article
  9. Review
  10. Review
  11. Modelling diabetic nephropathy in mice.Nature reviews. Nephrology · 2018
    Review
  12. Highlighting Diabetes Mellitus: The Epidemic Continues.Arteriosclerosis, thrombosis, and vascular biology · 2018
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Epigenetic Mechanisms of the Aging Human Retina.Journal of experimental neuroscience · 2015
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dustin E SchonesFrom the Department of Diabetes Complications and Metabolism, Beckman Research Institute of City of Hope, Duarte, CA. dschones@coh.org.
Amy LeungFrom the Department of Diabetes Complications and Metabolism, Beckman Research Institute of City of Hope, Duarte, CA.
Rama NatarajanFrom the Department of Diabetes Complications and Metabolism, Beckman Research Institute of City of Hope, Duarte, CA.
City of Hope · US

Funding

Inflammatory Gene Transcription In Diabetic ConditionsR01DK065073 · NIDDK · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI NATARAJAN, RAMA · 2003 to 2021
$7.9M
Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle CellsR01HL106089 · NHLBI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NATARAJAN, RAMA · 2011 to 2024
$6.6M
Transforming growth factor beta1, microRNAs, lncRNA and diabetic nephropathyR01DK081705 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NATARAJAN, RAMA · 2009 to 2023
$6.1M
ROLE OF 12-LIPOXYGENASE IN DIABETIC NEPHROPATHYR01DK058191 · NIDDK · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI NATARAJAN, RAMA · 2001 to 2016
$5.3M
Epigenetic Markers of Complications and Metabolic Memory in the DCCT/EDIC cohort.DP3DK106917 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NATARAJAN, RAMA · 2015 to 2015
$2.2M
ENDOCRINOLOGY, METABOLISM &NUTRITION TRAINING GRANTT32DK007571 · NIDDK · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI SWERDLOFF, RONALD SHERWIN · 1988 to 2013
$2.1M
Role of LncRNAs in diabetic liversK01DK104993 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI LEUNG, AMY Y · 2015 to 2017
$462k
NHLBI NIH HHS R01 HL106089NHLBI NIH HHS R01 HL106089-01NIDDK NIH HHS 1K01DK104993-01NIDDK NIH HHS DP3 DK106917NIDDK NIH HHS K01 DK104993NIDDK NIH HHS R01 DK058191NIDDK NIH HHS R01 DK065073NIDDK NIH HHS R01 DK081705NIDDK NIH HHS T32 DK007571NIDDK NIH HHS T32DK007571-24
6 · The paper itself

Abstract

The incidence of obesity across the globe has doubled over the past several decades, leading to escalating rates of diabetes mellitus, cardiovascular disease, and other complications. Given this dramatic rise in disease incidence, understanding the cause of these diseases is therefore of paramount importance. Metabolic diseases, such as obesity and diabetes mellitus, result from a multitude of genetic and environmental factors. Although the genetic basis of these diseases has been extensively studied, the molecular pathways whereby environmental factors influence disease progression are only beginning to be understood. One manner by which environmental factors can contribute to disease progression is through modifications to chromatin. The highly structured packaging of the genome into the nucleus through chromatin has been shown to be fundamental to tissue-specific gene regulation. Modifications to chromatin can regulate gene expression and are involved in a myriad of biological functions, and hence, disruption of these modifications is central to many human diseases. These modifications can furthermore be epigenetic in nature, thereby contributing to prolonged disease risk. Recent work has demonstrated that modifications to chromatin are associated with the progression of both diabetes mellitus and obesity, which is the subject of this review.

Indexed as

AnimalsBlood GlucoseCardiovascular DiseasesChromatinDiabetes MellitusDiabetic AngiopathiesEpigenesis, GeneticGene Expression RegulationHumansNutritional Physiological PhenomenaObesityBlood GlucoseChromatinchromatindiabetes mellitusepigenomicsgene–environment interactionobesity

Identifiers

PMID26044585
PMCPMC4482788
OpenAlexW2136494128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.